Interestingly, breast cancer patients treated with chemotherapy had significantly elevated IL-6 and TNF-α levels after approximately 5 years off-therapy, compared with healthy controls, with an interaction between these two cytokines (Kesler et al., 2013). Here, IL6 is linked to breast carcinoma.